Scientific Industries Reports Results for Second Quarter
Benchtop Lab Equipment Reports Record Revenues and Earnings Company Continues to Invest In Its Bioprocessing Business BOHEMIA, NY / ACCESSWIRE...
Year: 2021
Tree of Knowledge Announces Management Changes
TORONTO, ON / ACCESSWIRE / February 23, 2021 / Tree of Knowledge International Inc. (CSE:TOKI) ("TOKI" or the "Company") announces...
Novamind to Present at Benzinga Conference
Psychedelics panel discussion to feature Novamind's Chief Medical Officer TORONTO, ON / ACCESSWIRE / February 23, 2021 / Novamind Inc....
Northstar Biotech and USRM BOD Members Reinvest in the Company
SUNRISE, FL / ACCESSWIRE / February 23, 2021 / U.S. Stem Cell, Inc. (OTC PINK:USRM), a leader in the development...
American Kidney Fund Expands Rare Disease Resources with New Primary Hyperoxaluria Campaign
ROCKVILLE, MD / ACCESSWIRE / February 23, 2021 / As the nation prepares to observe Rare Disease Day on Feb....
Jaguar Health Launches Website for Napo EU
Site contains links to information about post-COVID-19 ‘long-hauler' syndrome An article published yesterday in the San Francisco Chronicle references diarrhea...
Medolife Rx And CURE Pharmaceutical Holding Corp. Collaborate For A Significant Increase Of Revenue
BURBANK, CA / ACCESSWIRE / February 23, 2021 / Medolife Rx, Inc., ("Medolife") a majority owned subsidiary of Quanta, Inc. (OTC PINK:QNTA),...
Virpax Begins IND Enabling Studies of Envelta(TM)
WEST CHESTER, PA / ACCESSWIRE / February 23, 2021 / Virpax® Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), today announced...
CLS Holdings USA, Inc. Manufacturing Arm Sees Strong Movement of New Products, Continues Toll Processing Transactions
LAS VEGAS, NV / ACCESSWIRE / February 23, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a...
Chemesis International Inc. Announces Agreement with The Pelican Group, a Leading Vending & Amusement Management Company
VANCOUVER, BC / ACCESSWIRE / February 23, 2021 / Chemesis International Inc. (CSE:CSI.U)(OTCQB:CADMF)(FRA: CWAB) (the "Company" or "Chemesis"), announces that...
Ovation Science Increases Access to U.S. Investors with Listing on OTCQB Under the Symbol OVATF
VANCOUVER, BC and LAS VEGAS, NV / ACCESSWIRE / February 23, 2021 / Ovation Science Inc. (CSE:OVAT)(OTCQB:OVATF) ("Ovation" or the "Company"), a topical and...
Evolus Announces Preliminary, Unaudited, Fourth Quarter and Full Year 2020 Net Revenue
Q4 2020 Net Revenue of $20.6 Million Increased 16% Over Q3 2020NEWPORT BEACH, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) --...
REPEAT – Pure Extracts Submits Application to Health Canada for Sales License
VANCOUVER, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
Jushi Holdings Inc.’s BEYOND / HELLO Retail Brand Launches New Personalized Customer Loyalty Program: “The Hello Club”
BOCA RATON, Fla., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF),...
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results
Xenon to Participate in Fireside Discussion at SVB Leerink 10th Annual Global Healthcare ConferenceBURNABY, British Columbia, Feb. 23, 2021 (GLOBE...
Supernus to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call
ROCKVILLE, Md., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
Cassava Sciences to Present at SVB Leerink Global Healthcare Conference
AUSTIN, Texas, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company developing product candidates...
ChemoCentryx to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call on Monday, March 1, 2021
MOUNTAIN VIEW, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's fourth quarter...
Antares Pharma to Report Fourth Quarter and Full-Year 2020 Financial and Operating Results
EWING, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today...
Albireo to Participate in Cowen and H.C. Wainwright Global Investor Conferences
BOSTON, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare pediatric liver disease company developing...
